Zobrazeno 1 - 10
of 50
pro vyhledávání: '"WANFENG GUO"'
Autor:
Clay D Jackson-Litteken, Wanfeng Guo, Brandon A Hogland, C Tyler Ratliff, LeAnn McFadden, Marissa S Fullerton, Daniel E Voth, Ryan O M Rego, Jon S Blevins
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 7, p e0012348 (2024)
Relapsing fever (RF), a vector-borne disease caused by Borrelia spp., is characterized by recurring febrile episodes due to repeated bouts of bacteremia. RF spirochetes can be geographically and phylogenetically divided into two distinct groups; Old
Externí odkaz:
https://doaj.org/article/96b34f5dc8854deaa9812a5f61955f9a
Autor:
Zhihua LI, Xiaoqing LIU, Jianjie LI, Hongjun GAO, Chuanhao TANG, Xiaoyan LI, Wanfeng GUO, Haifeng QIN, Weixia WANG, Lili QU, Jian CHEN
Publikováno v:
Chinese Journal of Lung Cancer, Vol 18, Iss 5, Pp 280-288 (2015)
Background and objective Small-cell lung cancer (SCLC) is an aggressive disease for which the mainstay of treatment is cytotoxic chemotherapy. Despite good initial responses most patients will relapse or progress after the first-line therapy. The evi
Externí odkaz:
https://doaj.org/article/7a139490094043b1b7b9862708762e0d
Autor:
Jing XU, Xiaoqing LIU, Hongjun GAO, Wanfeng GUO, Chuanhao TANG, Xiaoyan LI, Jianjie LI, Haifeng QIN, Weixia WANG, Lili QU, Hong WANG, Hui YANG, Lin YANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 18, Iss 5, Pp 308-314 (2015)
Background and objective Gemcitabine and taxanes are effective agents commonly used in advanced squamous lung cancer. The best treatment sequence, however, is unclear to our knowledge. So we conducted this retrospective study in order to compare the
Externí odkaz:
https://doaj.org/article/3524fde79e0a4a0baee2212b25ebaa24
Autor:
Chuanhao TANG, Xiaoyan LI, Wanfeng GUO, Jianjie LI, Haifeng QIN, Weixia WANG, Lili QU, Juan AN, Hongjun GAO, Xiaoqing LIU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 16, Iss 7, Pp 345-352 (2013)
Background and objective For advanced non-small cell lung cancer (NSCLC) patients who benefited from prior epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy, the choice of a second TKI therapy has gradually become a new st
Externí odkaz:
https://doaj.org/article/306f9f1a5d1f472c98dad8360d891639
Autor:
Juan AN, Chuanhao TANG, Na WANG, Yi LIU, Wanfeng GUO, Xiaoyan LI, Zihe WANG, Kun HE, Xiaoqing LIU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 16, Iss 5, Pp 233-239 (2013)
Background and objective The improved survival of patients with lung cancer depends on early diagnosis of lung cancer. However, the traditional diagnostic techniques have several limitations. Mass spectrometry (MS) has been applied as a core technolo
Externí odkaz:
https://doaj.org/article/c7a70eca221e4ceaa6b514ef99d51cf3
Autor:
Lili QU, Haifeng QIN, Xiaoqing LIU, Hongjun GAO, Jianjie LI, Weixia WANG, Chuanhao TANG, Wanfeng GUO, Xiaoyan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 16, Iss 2, Pp 73-77 (2013)
Background and objective The incidence of young non-small cell lung cancer (NSCLC) annually increases. The aim of this study is to analyze the clinical pathological characteristics of young (less than 40 years old) NSCLC patients. Methods The data of
Externí odkaz:
https://doaj.org/article/4b1a526c976b453cb1e15832ff8ebd6f
Autor:
Jianjie LI, Lili QU, Xing Wei, Hongjun GAO, Weixia WANG, Haifeng QIN, Chuanhao TANG, Wanfeng GUO, Hong WANG, Xiaoqing LIU
Publikováno v:
Chinese Journal of Lung Cancer, Vol 15, Iss 5, Pp 299-304 (2012)
Background and objective It has been proven that epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) significantly benefits advanced non-small cell lung cancer (NSCLC) patients harboring EGFR mutations in progression-free survival t
Externí odkaz:
https://doaj.org/article/cd91ad1318eb4b1b855672a5149f9066
Publikováno v:
Chinese Journal of Lung Cancer, Vol 15, Iss 2, Pp 117-121 (2012)
Background and objective Pemetrexed in combination with platinum or a single-agent has been approved for the first- and second-line treatment of non-small cell lung cancer (NSCLC). However, the role of pemetrexed therapy in the third-line and beyond
Externí odkaz:
https://doaj.org/article/23e2e901f09d40aea57d3ff95a0f39ce
Publikováno v:
Chinese Journal of Lung Cancer, Vol 13, Iss 9, Pp 861-866 (2010)
Background and objective It has been shown that carbonic anhydrase IX (CAIX) was closely related to tumor hypoxia. Proliferating cell nuclear antigen (Ki67) is considered to be an objective indicator which could reliable and comprehensive response to
Externí odkaz:
https://doaj.org/article/8d63dc4ccd3d4d5eadde9663d4c8c3a0
Publikováno v:
Chinese Journal of Lung Cancer, Vol 16, Iss 6, Pp 330-332 (2013)
Externí odkaz:
https://doaj.org/article/aa66c615b96b411093d2c7e698b04feb